These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
332 related articles for article (PubMed ID: 9815619)
1. Altered p16/MTS1/CDKN2 and cyclin D1/PRAD-1 gene expression is associated with the prognosis of squamous cell carcinoma of the esophagus. Takeuchi H; Ozawa S; Ando N; Shih CH; Koyanagi K; Ueda M; Kitajima M Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2229-36. PubMed ID: 9815619 [TBL] [Abstract][Full Text] [Related]
2. Cyclin D1 amplification as a new predictive classification for squamous cell carcinoma of the esophagus, adding gene information. Shinozaki H; Ozawa S; Ando N; Tsuruta H; Terada M; Ueda M; Kitajima M Clin Cancer Res; 1996 Jul; 2(7):1155-61. PubMed ID: 9816282 [TBL] [Abstract][Full Text] [Related]
3. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines. Sartor M; Steingrimsdottir H; Elamin F; Gäken J; Warnakulasuriya S; Partridge M; Thakker N; Johnson NW; Tavassoli M Br J Cancer; 1999 Apr; 80(1-2):79-86. PubMed ID: 10389982 [TBL] [Abstract][Full Text] [Related]
4. [Loss of CDKN2 gene and amplification of cyclin D1 gene in human esophageal cancer]. Zheng J; Hou P; Zhou C Zhonghua Zhong Liu Za Zhi; 1996 Nov; 18(6):408-11. PubMed ID: 9387288 [TBL] [Abstract][Full Text] [Related]
5. Concomitant analysis of p16/INK4, cyclin D1, and retinoblastoma protein expression in esophageal squamous cell carcinoma. Nakamura T; Ide H; Eguchi R; Hayashi K; Takasaki K Hepatogastroenterology; 2003; 50(53):1321-6. PubMed ID: 14571727 [TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors. Namazie A; Alavi S; Olopade OI; Pauletti G; Aghamohammadi N; Aghamohammadi M; Gornbein JA; Calcaterra TC; Slamon DJ; Wang MB; Srivatsan ES Laryngoscope; 2002 Mar; 112(3):472-81. PubMed ID: 12148857 [TBL] [Abstract][Full Text] [Related]
7. Infrequent alternations of RB pathway (Rb-p16INK4A-cyclinD1) in adenoid cystic carcinoma of salivary glands. Shintani S; Mihara M; Nakahara Y; Kiyota A; Yoshihama Y; Ueyama Y; Matsumura T Anticancer Res; 2000; 20(3B):2169-75. PubMed ID: 10928172 [TBL] [Abstract][Full Text] [Related]
9. Differential expression of key cell cycle genes (p16/cyclin D1/pRb) in head and neck squamous carcinomas. Lai S; El-Naggar AK Lab Invest; 1999 Mar; 79(3):255-60. PubMed ID: 10092061 [TBL] [Abstract][Full Text] [Related]
10. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence. Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644 [TBL] [Abstract][Full Text] [Related]
11. Alterations of expression of Rb, p16(INK4A) and cyclin D1 in non-small cell lung carcinoma and their clinical significance. Brambilla E; Moro D; Gazzeri S; Brambilla C J Pathol; 1999 Aug; 188(4):351-60. PubMed ID: 10440744 [TBL] [Abstract][Full Text] [Related]
12. Further evidence that altered p16/CDKN2 gene expression is associated with lymph node metastasis in squamous cell carcinoma of the esophagus. Takeuchi H; Ozawa S; Ando N; Kitagawa Y; Mukai M; Ueda M; Kitajima M Oncol Rep; 2001; 8(3):627-32. PubMed ID: 11295092 [TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma. Okami K; Reed AL; Cairns P; Koch WM; Westra WH; Wehage S; Jen J; Sidransky D Oncogene; 1999 Jun; 18(23):3541-5. PubMed ID: 10376532 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical characterization of p57KIP2 expression in human esophageal squamous cell carcinoma. Matsumoto M; Furihata M; Ohtsuki Y; Sasaguri S; Ogoshi S Anticancer Res; 2000; 20(3B):1947-52. PubMed ID: 10928132 [TBL] [Abstract][Full Text] [Related]
16. Simultaneous deregulation of p16 and cyclin D1 genes in pancreatic ductal adenocarcinoma: a combined immunohistochemistry and image analysis study based on tissue microarrays. Tsiambas E; Karameris A; Gourgiotis S; Salemis N; Athanassiou AE; Karakitsos P; Papalois A; Merikas E; Kosmidis P; Patsouris E J BUON; 2007; 12(2):261-7. PubMed ID: 17600882 [TBL] [Abstract][Full Text] [Related]
17. Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue. Bova RJ; Quinn DI; Nankervis JS; Cole IE; Sheridan BF; Jensen MJ; Morgan GJ; Hughes CJ; Sutherland RL Clin Cancer Res; 1999 Oct; 5(10):2810-9. PubMed ID: 10537346 [TBL] [Abstract][Full Text] [Related]
18. Modes of silencing of p16 in development of esophageal squamous cell carcinoma. Tokugawa T; Sugihara H; Tani T; Hattori T Cancer Res; 2002 Sep; 62(17):4938-44. PubMed ID: 12208744 [TBL] [Abstract][Full Text] [Related]
19. Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma. Dreyling MH; Bullinger L; Ott G; Stilgenbauer S; Müller-Hermelink HK; Bentz M; Hiddemann W; Döhner H Cancer Res; 1997 Oct; 57(20):4608-14. PubMed ID: 9377576 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of E2F-1 is associated with increased disease-free survival in squamous cell carcinoma of the anterior tongue. Kwong RA; Nguyen TV; Bova RJ; Kench JG; Cole IE; Musgrove EA; Henshall SM; Sutherland RL Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3705-11. PubMed ID: 14506162 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]